| International, randomized, placebo-controlled, double-blind phase III study of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous non-small-cell lung … GV Scagliotti, I Vynnychenko, K Park, Y Ichinose, K Kubota, FH Blackhall, ... | 196 | 2012 |
| An international, randomized, placebo-controlled, double-blind phase III study (MONET1) of motesanib plus carboplatin/paclitaxel (C/P) in patients with advanced nonsquamous non … G Scagliotti, I Vynnychenko, Y Ichinose, K Park, K Kubota, FH Blackhall, ... Journal of Clinical Oncology 29 (18_suppl), LBA7512-LBA7512, 2011 | 29 | 2011 |
| Motesanib plus carboplatin/paclitaxel in patients with advanced squamous non-small-cell lung cancer SO Novello S., Scagliotti G.V., Vynnychenko I Journal of Thoracic Oncology - 9 (8), P.1154-1161., 2014 | 18* | 2014 |
| Молекулярные маркеры прогрессирования колоректального рака АП Колесник, ИД Паламарчук, АМ Сидоренко Онкологія, 2006 | 18 | 2006 |
| MONET 1-AN INTERNATIONAL, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF MOTESANIB IN COMBINATION WITH CARBOPLATIN/PACLITAXEL IN PATIENTS WITH ADVANCED … G Scagliotti, I Vynnychenko, Y Ichinose, K Park, K Kubota, F Blackhall, ... JOURNAL OF THORACIC ONCOLOGY 6 (6), S276-S277, 2011 | | 2011 |
